Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leukemia Chronic Lymphocytic Leukemia (CLL)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT00904514
What this trial is testing

Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 241
Early research (Phase 1)Study completedNCT00040950
What this trial is testing

Biological Therapy Plus Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)WithdrawnNCT01131247
What this trial is testing

PH2 Trial in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) With a Combination of Bendamustine & Ofatumumab

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)
Nevada Cancer Institute 37
Large-scale testing (Phase 3)Study completedNCT01892618
What this trial is testing

Pneumococcal Vaccine in Untreated CLL Patients

Who this might be right for
Chronic Lymphocytic Leukemia
Karolinska University Hospital 134
Testing effectiveness (Phase 2)Study completedNCT04883749
What this trial is testing

Efficacy of Acalabrutinib in Very Old or Frail Patients With Treatment-naïve or Relapsed/Refractory CLL

Who this might be right for
Chronic Lymphoid Leukemia
German CLL Study Group 53
Testing effectiveness (Phase 2)Ended earlyNCT04730349
What this trial is testing

Bempegaldesleukin (BEMPEG: NKTR-214) in Combination With Nivolumab in Children, Adolescents and Young Adults With Recurrent or Treatment-resistant Cancer

Who this might be right for
EpendymomaEwing SarcomaHigh-grade Glioma+7 more
Bristol-Myers Squibb 15
Testing effectiveness (Phase 2)Looking for participantsNCT06697184
What this trial is testing

Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.

Who this might be right for
Chronic Lymphocytic LeukemiaCLLMantle Cell Lymphoma+1 more
BeOne Medicines 258
Testing effectiveness (Phase 2)Looking for participantsNCT04941716
What this trial is testing

Acalabrutinib in Combination With Venetoclax for the Treatment of Refractory or Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, The AVENUE-2 Trial

Who this might be right for
Recurrent Chronic Lymphocytic LeukemiaRecurrent Small Lymphocytic LymphomaRefractory Chronic Lymphocytic Leukemia+1 more
Fred Hutchinson Cancer Center 20
Testing effectiveness (Phase 2)Study completedNCT00858117
What this trial is testing

A Phase II Trial of Alemtuzumab and Rituximab in Patients With Previously Untreated CLL

Who this might be right for
Leukemia
Northwestern University 30
Not applicableStudy completedNCT01030913
What this trial is testing

B-type Chronic Lymphocytic Leukemia (B-CLL) Subgroups: Maturation Stage and Gene Expression

Who this might be right for
Chronic Lymphocytic Leukemia
Northwell Health 1,248
Testing effectiveness (Phase 2)Active Not RecruitingNCT05650723
What this trial is testing

Zanubrutinib and Venetoclax as Initial Therapy for Chronic Lymphocytic Leukemia (CLL) With Response-based Obinutuzumab

Who this might be right for
Leukemia, Lymphocytic, Chronic, B-Cell
Weill Medical College of Cornell University 50
Testing effectiveness (Phase 2)Ended earlyNCT02877082
What this trial is testing

Tacrolimus, Bortezomib, & Thymoglobulin in Preventing Low Toxicity GVHD in Donor Blood Stem Cell Transplant Patients

Who this might be right for
Acute LeukemiaChronic Lymphocytic LeukemiaChronic Myelogenous Leukemia, BCR-ABL1 Positive+9 more
Emory University 5
Early research (Phase 1)Ended earlyNCT00098488
What this trial is testing

17-N-Allylamino-17-Demethoxygeldanamycin With or Without Rituximab in Treating Patients With Relapsed B-Cell Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia

Who this might be right for
B-cell Chronic Lymphocytic LeukemiaProlymphocytic LeukemiaRefractory Chronic Lymphocytic Leukemia
National Cancer Institute (NCI) 30
Very early researchStudy completedNCT02144623
What this trial is testing

Pretreatment With Valproate Prior to Immunotherapy Targeting Cluster of Differentiation Antigen 20 in Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
Lund University Hospital 4
Not applicableUnknownNCT03847727
What this trial is testing

Bendamustine and Rituximab (BR) as Induction and Maintenance in Relapsed and Refractory Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
Pirogov Russian National Research Medical University 112
Testing effectiveness (Phase 2)Active Not RecruitingNCT03128879
What this trial is testing

Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL

Who this might be right for
Chronic Lymphocytic Leukemia
M.D. Anderson Cancer Center 59
Testing effectiveness (Phase 2)Study completedNCT01627054
What this trial is testing

A Phase II Study of AT7519M, a CDK Inhibitor, in Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
NCIC Clinical Trials Group 7
Testing effectiveness (Phase 2)Study completedNCT00632359
What this trial is testing

Lenalidomide in Chronic Lymphocytic Leukemia (CLL) Patients With Residual Disease

Who this might be right for
Chronic Lymphocytic Leukemia
M.D. Anderson Cancer Center 33
Testing effectiveness (Phase 2)Study completedNCT00026182
What this trial is testing

Rituximab and Interleukin-12 in Treating Patients With B-Cell Non-Hodgkin's Lymphoma

Who this might be right for
Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaRecurrent Grade 1 Follicular Lymphoma+4 more
National Cancer Institute (NCI) 99
Testing effectiveness (Phase 2)Ended earlyNCT01119794
What this trial is testing

Ofatumumab and Bortezomib for Patients With Low-grade B-cell Non-hodgkin Lymphoma That Relapse After Rituximab

Who this might be right for
Lymphoma, Non-Hodgkins
Brown University 10
Next Page